These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16914561)

  • 1. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.
    Daniel C; Radeke HH; Sartory NA; Zahn N; Zuegel U; Steinmeyer A; Stein J
    J Pharmacol Exp Ther; 2006 Nov; 319(2):622-31. PubMed ID: 16914561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 22-ene-25-oxa-vitamin D: a new vitamin D analogue with profound immunosuppressive capacities.
    Daniel C; Schlauch T; Zügel U; Steinmeyer A; Radeke HH; Steinhilber D; Stein J
    Eur J Clin Invest; 2005 May; 35(5):343-9. PubMed ID: 15860047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions.
    Daniel C; Sartory NA; Zahn N; Schmidt R; Geisslinger G; Radeke HH; Stein JM
    Mol Immunol; 2007 Jul; 44(13):3305-16. PubMed ID: 17475330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect.
    Gotsman I; Shlomai A; Alper R; Rabbani E; Engelhardt D; Ilan Y
    J Pharmacol Exp Ther; 2001 Jun; 297(3):926-32. PubMed ID: 11356912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinomenine attenuates 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in mice.
    Cheng H; Xia B; Guo Q; Zhang L; Wang F; Jiang L; Wang Z; Zhang Y; Li C
    Int Immunopharmacol; 2007 May; 7(5):604-11. PubMed ID: 17386408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive effects of Schistosoma japonicum ova on trinitrobenzenesulfonic acid-induced colitis and bacterial translocation in mice.
    Zhao Y; Zhang S; Jiang L; Jiang J; Liu H
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1775-80. PubMed ID: 20136961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis.
    Bhatia M; Landolfi C; Basta F; Bovi G; Ramnath RD; de Joannon AC; Guglielmotti A
    Inflamm Res; 2008 Oct; 57(10):464-71. PubMed ID: 18827968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changtai granule, a traditional Chinese drug, protects hapten-induced colitis by attenuating inflammatory and immune dysfunctions.
    Liu BG; Jia XM; Cao YY; Chen SH; Gao PH; Wang Y; Jiang YY; Cao YB
    J Ethnopharmacol; 2008 Jan; 115(1):1-8. PubMed ID: 17964746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fumigaclavine C, an fungal metabolite, improves experimental colitis in mice via downregulating Th1 cytokine production and matrix metalloproteinase activity.
    Wu XF; Fei MJ; Shu RG; Tan RX; Xu Q
    Int Immunopharmacol; 2005 Sep; 5(10):1543-53. PubMed ID: 16023606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease.
    Laverny G; Penna G; Vetrano S; Correale C; Nebuloni M; Danese S; Adorini L
    Immunol Lett; 2010 Jun; 131(1):49-58. PubMed ID: 20350569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in the immune system.
    Bemiss CJ; Mahon BD; Henry A; Weaver V; Cantorna MT
    Arch Biochem Biophys; 2002 Jun; 402(2):249-54. PubMed ID: 12051670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive activity of a new pteridine derivative (4AZA1378) alleviates severity of TNBS-induced colitis in mice.
    Shen C; Dillissen E; Kasran A; Lin Y; Herman J; Sienaert I; De Jonghe S; Kerremans L; Geboes K; Boon L; Rutgeerts P; Ceuppens JL
    Clin Immunol; 2007 Jan; 122(1):53-61. PubMed ID: 17070110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
    Gonzalez-Rey E; Delgado M
    Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
    J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peroxisome proliferator-activated receptor (PPAR) gamma: a new target for the treatment of inflammatory bowel disease].
    Dubuquoy L; Bourdon C; Peuchmaur M; Leibowitz MD; Nutten S; Colombel JF; Auwerx J; Desreumaux P
    Gastroenterol Clin Biol; 2000; 24(8-9):719-24. PubMed ID: 11011247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.